RYAN CROWDER: Open Payments
NPI 1558784728 · FAYETTEVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,668 in 54 payments from 10 companies in 2025. Trend: 2023 $1,042 · 2024 $1,224 · 2025 $4,668
Consulting: $2,200Travel & lodging: $1,172Food & beverage: $1,163Education: $133
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 12 | $3,789 |
| Novartis Pharmaceuticals Corporation | 12 | $271 |
| ABBVIE INC. | 8 | $202 |
| GENZYME CORPORATION | 4 | $125 |
| Janssen Biotech, Inc. | 5 | $104 |
| Lilly USA, LLC | 4 | $80 |
| Incyte Corporation | 2 | $34 |
| Organon LLC | 5 | $25 |
| Amgen Inc. | 1 | $20 |
| PFIZER INC. | 1 | $17 |
Products named: Odomzo, SKYRIZI, COSENTYX, TREMFYA, DUPIXENT, Rhapsido, ILUMYA, TALTZ.
Industry payments across AR — which companies pay providers there.
